GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Concord Healthcare Group Co Ltd (HKSE:02453) » Definitions » Net Income

Concord Healthcare Group Co (HKSE:02453) Net Income : HK$-474.8 Mil (TTM As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Concord Healthcare Group Co Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Concord Healthcare Group Co's Net Income for the six months ended in Dec. 2024 was HK$-279.0 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2024 was HK$-474.8 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Concord Healthcare Group Co's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was HK$-0.39.


Concord Healthcare Group Co Net Income Historical Data

The historical data trend for Concord Healthcare Group Co's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Concord Healthcare Group Co Net Income Chart

Concord Healthcare Group Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Income
-691.42 -999.89 -604.59 -408.08 -473.22

Concord Healthcare Group Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Net Income Get a 7-Day Free Trial -178.90 -212.50 -195.58 -195.80 -279.03

Concord Healthcare Group Co Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Concord Healthcare Group Co's Net Income for the fiscal year that ended in Dec. 2024 is calculated as

Net Income(A: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-518.727+1.101+0+44.409
=-473.2

Concord Healthcare Group Co's Net Income for the quarter that ended in Dec. 2024 is calculated as

Net Income(Q: Dec. 2024 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=-300.365+-1.572+0+22.904
=-279.0

Net Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-474.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Concord Healthcare Group Co  (HKSE:02453) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Concord Healthcare Group Co's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Concord Healthcare Group Co Net Income Related Terms

Thank you for viewing the detailed overview of Concord Healthcare Group Co's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Concord Healthcare Group Co Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Guanghua Road, Room 26A1-26A5, East Tower, Hanwei Building, Chaoyang, Beijing, CHN, 100020
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is primarily generated from its hospital business and its medical equipment, software, and related services segment.
Executives
Ascendium Group Limited
Concord Medical Services Holdings Limited
Morgancreek Investment Holdings Limited
Yang Jianyu
Zhang Bi
Shanghai Medstar Financial Leasing Company Limited
China International Capital Corporation Limited
Zhong Jin Zi Ben Yun Ying You Xian Gong Si
Zhong Jin Jia Tai Er Qi Tian Jin Gu Quan Tou Zi Ji Jin He Huo Qi Ye You Xian He Huo
Beijing Concord Medical Technology Co., Ltd.
Concord Hospital Management Group Limited
Tianjin Concord Medical Technology Co., Ltd.

Concord Healthcare Group Co Headlines

No Headlines